Seeing Is Believing
Vascular Biogenics Ltd's activity chart (see below) currently has 15 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 51.04% with an average time for these price targets to be met of 277.38 days.
Most recent stock forecast was given by MATTHEW BARCUS from CHARDAN CAPITAL on 21-Jul-2022. First documented stock forecast 20-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Jul-2022
$5
4 years 3 months 22 days ago
(21-Jul-2022)
1/1 (100%)
$-52.05 (-91.24%)
166
Buy Since 15-Oct-2018
$140
4 years 3 months 22 days ago
(20-Jul-2022)
1/4 (25%)
$51.8 (58.73%)
90
Buy Since 27-Jun-2019
$105
$102.24 (3704.35%)
$70
6 years 6 months 25 days ago
(17-Apr-2020)
1/2 (50%)
$57.4 (120.59%)
552
Hold Since 08-Mar-2018
$105
$102.24 (3704.35%)
$875
8 years 8 months 3 days ago
(08-Mar-2018)
1/3 (33.33%)
$12.25 (13.21%)
90
Buy Since 09-Nov-2015
$140
$137.24 (4972.46%)
$455
8 years 8 months 3 days ago
(08-Mar-2018)
0/4 (0%)
$47.25 (50.94%)
What is VBLT (Vascular Biogenics Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on VBLT (Vascular Biogenics Ltd)?
Which analyst has the current lower performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?
Which analyst has the most public recommendations on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most bullish on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most reserved on VBLT (Vascular Biogenics Ltd)?